Coroflex ISAR NEO "All Comers" Post Market Clinical Follow-up (PMCF)

NCT03809715 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3520

Last updated 2026-01-08

No results posted yet for this study

Summary

The aim of the study is to assess the safety and efficacy of the device to treat coronary de novo and restenotic lesions.

Conditions

Interventions

DEVICE

Coroflex® ISAR NEO coronary stent system

treatment of coronary artery disease with Coroflex® ISAR NEO of "real world" de-novo and restenotic lesions in native coronary arteries and coronary bypass grafts

Sponsors & Collaborators

  • B. Braun Melsungen AG

    lead INDUSTRY

Principal Investigators

  • Rene Koning, MD · Clinique St. Hilaire

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-17
Primary Completion
2024-05-31
Completion
2025-08-15

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03809715 on ClinicalTrials.gov